A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD
NCT00242333
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
COPD
Interventions
DRUG:
AD 237
Sponsor
Sosei
Collaborators
[object Object]